Best hospitals for Oncology: A 2026-2027 evidence review

People researching the best hospitals for Oncology will find that national rankings identify several prominent cancer centers, but rankings alone do not determine the most appropriate hospital for an individual diagnosis. The 2026-2027 data place MD Anderson Cancer Center first in U.S. News cancer-care rankings, followed by Memorial Sloan Kettering, Dana-Farber Brigham Cancer Center, Mayo Clinic, and Massachusetts General Hospital. 1

What the 2026-2027 rankings show

U.S. News & World Report’s 2026-2027 cancer list ranks the top 50 hospitals for adult cancer treatment. MD Anderson received a score of 99.3 out of 100, while Memorial Sloan Kettering scored 88.7. Dana-Farber Brigham Cancer Center scored 84.8, Mayo Clinic scored 82.6, and Massachusetts General Hospital scored 81.0. The five leading hospitals remained unchanged from the prior edition. 12

The remaining U.S. News top 10 include Johns Hopkins Hospital, Hospital of the University of Pennsylvania, Northwestern Medicine-Northwestern Memorial Hospital, Stanford Health Care-Stanford Hospital, and a tie between Mount Sinai Hospital and UCSF Health-UCSF Medical Center. U.S. News also introduced regional cancer evaluations intended to identify strong hospitals that may be more accessible to patients outside the nationally ranked group. 1

Leading hospitals and their clinical scope

MD Anderson is an NCI-designated Comprehensive Cancer Center devoted to cancer care, research, education, and prevention. Its programs cover multidisciplinary treatment and specialized services across many cancer types. The institution reported nearly 27,000 employees, including more than 2,000 faculty, and stated that it invested $1.3 billion in research during fiscal year 2025. 47

Memorial Sloan Kettering provides cancer diagnosis, surgery, radiation, systemic therapy, condition-specific programs, and clinical research in New York and New Jersey. Mayo Clinic describes a multidisciplinary model involving medical oncology, radiation oncology, surgery, pathology, imaging, genetics, and supportive care. Dana-Farber provides adult and pediatric treatment, research, and clinical trials through its academic cancer programs. 6910

Why cancer type should guide hospital selection

A hospital’s overall oncology rank does not necessarily measure its performance for every tumor type, stage, or treatment plan. Newsweek’s 2026 specialized-care evaluation identified MD Anderson, Mayo Clinic Rochester, Memorial Sloan Kettering, Dana-Farber Brigham Cancer Center, Cleveland Clinic, Massachusetts General Hospital, Johns Hopkins, Mayo Clinic Phoenix, and UCSF among highly rated cancer hospitals, with specialties varying by institution. 3

Patients and clinicians may therefore compare expertise in the specific cancer involved, such as breast, lung, colorectal, cervical, prostate cancer, leukemia, or other diseases listed in the hospital’s programs. Important questions include whether the center has a dedicated multidisciplinary team, experience with the relevant procedure, access to pathology review, genetic counseling, radiation options, and clinical trials appropriate to the diagnosis and eligibility criteria. 36

Research, designation, and oversight

NCI designation is a useful quality signal, but it is not a universal ranking. The National Cancer Institute describes Comprehensive Cancer Centers as institutions with strength in laboratory, clinical, and population-based cancer research. MD Anderson and City of Hope are examples of centers identified in the research data as NCI-designated Comprehensive Cancer Centers. 78

The American College of Surgeons Commission on Cancer accredits cancer programs that meet standards for multidisciplinary services, quality improvement, data management, and patient support. Medicare Care Compare supplies hospital-level information on safety, patient experience, quality measures, and selected outcomes. These oversight and reporting systems can add context to a ranking, although they do not replace a physician’s assessment of diagnosis-specific appropriateness. 10

Access, insurance, and continuity of care

Highly specialized hospitals may require substantial travel, coordination among multiple departments, and repeated visits for consultations, infusion, radiation, surgery, or follow-up. Insurance network rules, referral requirements, prior authorization, lodging, transportation, and communication between the tertiary center and a local oncologist can affect whether a treatment plan is practical. These logistical factors are part of eligibility and access, not merely administrative details.

Local accredited cancer programs may be suitable for routine treatment and can make family involvement and follow-up easier. A patient may seek a second opinion at a nationally recognized center while receiving portions of care closer to home, depending on the medical team, insurer, and treatment plan. City of Hope, for example, describes a network of cancer centers in several U.S. regions and access to more than 700 clinical trials, but availability depends on diagnosis and study criteria. 8

How to interpret rankings responsibly

Rankings are comparative research tools, not guarantees of outcomes for an individual. Methodologies can differ between organizations: U.S. News assigns numerical scores and national positions, while Newsweek evaluates specialized care using clinical performance, patient outcomes, expert input, and patient-reported measures. Newsweek’s global oncology list has also placed international hospitals such as Samsung Medical Center and Asan Medical Center in Seoul, Gustave Roussy in France, and The Royal Marsden Hospital in the United Kingdom among leading centers. 135

Before choosing a hospital, the relevant medical team should confirm diagnosis, stage, treatment alternatives, trial eligibility, expected monitoring, and how urgent care will be handled. Patients should also verify accreditation, insurance participation, second-opinion procedures, supportive services, and the division of responsibilities between the specialist center and local providers. The most appropriate hospital is the one whose disease-specific expertise, evidence-based options, safety systems, and ongoing care arrangements fit the patient’s clinical and practical circumstances.

Sources

1. The ASCO Post, U.S. News & World Report Announces 2026-2027 Best Cancer Hospitals: https://ascopost.com/news/august-2026/us-news-world-report-announces-2026-2027-best-cancer-hospitals/
2. Oncology News Central, Best Cancer Hospitals 2026-27: U.S. News Rankings: https://www.oncologynewscentral.com/oncology/us-news-releases-2026-2027-cancer-hospital-rankings
3. Newsweek Rankings, America’s Best Hospitals for Specialized Care 2026: Cancer Care: https://rankings.newsweek.com/americas-best-hospitals-for-specialized-care-2026/cancer-care
4. UT MD Anderson Cancer Center, 2026 ranking announcement: https://www.mdanderson.org/newsroom/ut-md-anderson-ranks-number-one-in-the-nation-for-cancer-care-for-12th-year-in-a-row.h00-159857712.html
5. Healio, UT MD Anderson once again named nation’s best cancer hospital: https://www.healio.com/news/hematology-oncology/20260804/ut-md-anderson-once-again-named-nations-best-cancer-hospital
6. Verywell Health, Top Hospitals for Cancer Care in the U.S.: https://www.verywellhealth.com/best-hospitals-for-cancer-treatment-514514
7. National Cancer Institute, UT MD Anderson: https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson
8. City of Hope, cancer treatment and research center: https://www.cityofhope.org/
9. Memorial Sloan Kettering Cancer Center: https://www.mskcc.org/
10. Research references for Mayo Clinic, Dana-Farber, ACS Commission on Cancer, and Medicare Care Compare